Physician profile
Kevin E Wasco
NPI 1497705008
$6,224.84
in general payments reported to CMS, 2019-2025
27 companies · $762 in 2025
The $762 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,241 · 2020: $96.86 · 2021: $501 · 2022: $184 · 2023: $258 · 2024: $1,182 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129 · Honoraria: $520 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Travel and Lodging: $52.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.44 |
| Honoraria | $520.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Travel and Lodging | $52.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $1,344.00 | 2019-2021 | |
| Intuitive Surgical, INC. | $984.28 | 2019-2024 | |
| Medical Device Business Services, INC. | $897.01 | 2019 | |
| Covidien LP | $598.61 | 2019 | |
| Becton, Dickinson and Company | $520.00 | 2025 | |
| W. L. Gore & Associates, INC. | $354.90 | 2021-2024 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Gore Synecor Biomaterial |
| Ethicon US, LLC | $299.51 | 2019-2023 | Echelon; Endopath, Linx Reflux Management System, Surgicel Nu-Knit |
| Erbe USA INC | $161.16 | 2019 | |
| Sanara Medtech INC. | $138.91 | 2021-2022 | |
| Integra Lifesciences Corporation | $132.66 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Boston Scientific Corporation | $128.50 | 2024 | Apollo Revise System, Apollo Esg System |
| Apollo Endosurgery US INC | $105.33 | 2023 | Overstitch Endoscopic Suturing System |
| Lumendi LLC | $75.67 | 2021 | |
| Medtronic, INC. | $73.91 | 2025 | Ligasure, Progrip |
| Abbvie INC. | $69.58 | 2019-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $63.52 | 2024-2025 | Fibryga |
| Mauna Kea Technologies, INC. | $57.06 | 2020-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.40 | 2021-2022 | |
| Tela Bio, INC. | $34.30 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Janssen Biotech, INC. | $23.95 | 2025 | Tremfya |
| Teleflex LLC | $22.74 | 2025 | Titan Sgs Bailout Chuck |
| Lemaitre Vascular, INC. | $20.73 | 2024 | Artegraft Vascular Graft |
| Olympus America INC. | $20.70 | 2019 | |
| Atricure, INC. | $17.04 | 2024 | |
| Novo Nordisk INC | $14.45 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $13.98 | 2020 | |
| Urgo Medical North America, LLC | $13.94 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Wasco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.